Quipt Home Medical Corp. - Laporan Laba Rugi (TTM)

Quipt Home Medical Corp.
CA ˙ TSX ˙ CA74880P1045
CA$ 3.58 0.00 (0.00%)
2025-09-05
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Quipt Home Medical Corp. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 73 79 81 87 94 99 109 118 128 139 164 189 212 236 241 244 246 245 241 238
Change (%) 8.52 2.67 7.39 8.60 4.62 10.56 8.00 8.24 8.95 18.16 14.95 12.07 11.36 2.38 1.20 0.69 -0.48 -1.58 -1.03
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 20 21 23 25 28 30 31 32 33 36 43 51 58 66 67 68 69 69 67 65
Change (%) 7.40 6.32 11.11 11.38 5.64 4.15 3.74 3.30 7.27 21.20 17.89 13.73 13.51 2.68 0.09 2.04 -0.19 -2.23 -2.71
% of Revenue 27.44 27.16 28.13 29.10 29.85 30.14 28.39 27.27 26.02 25.62 26.28 26.95 27.35 27.88 27.96 27.66 28.03 28.11 27.93 27.45
Gross Operating Profit 53 57 58 62 66 69 78 86 94 103 121 138 154 170 174 177 177 176 174 173
Change (%) 8.94 1.31 5.94 7.46 4.18 13.33 9.69 10.10 9.53 17.11 13.91 11.46 10.55 2.27 1.63 0.17 -0.60 -1.33 -0.37
% of Revenue 72.56 72.84 71.87 70.90 70.15 69.86 71.61 72.73 73.98 74.38 73.72 73.05 72.65 72.12 72.04 72.34 71.97 71.89 72.07 72.55
SG&A 39 39 39 42 50 54 63 68 71 75 87 98 109 119 122 123 125 125 124 126
Change (%) 1.59 -1.54 9.32 16.94 8.02 16.72 8.24 4.43 6.38 15.39 12.87 10.78 9.90 2.02 1.36 1.39 -0.14 -0.97 1.69
% of Revenue 53.41 50.00 47.94 48.80 52.55 54.26 57.28 57.41 55.39 54.08 52.82 51.86 51.26 50.59 50.41 50.49 50.84 51.02 51.34 52.75
R&D
Change (%)
% of Revenue
OpEx 73 75 77 85 96 102 114 121 122 131 154 180 208 232 239 241 245 244 242 242
Change (%) 3.16 1.79 10.07 13.06 7.22 11.43 6.05 0.81 7.13 17.78 16.88 15.34 11.76 2.95 0.84 1.50 -0.17 -0.81 0.14
% of Revenue 100.68 95.70 94.88 97.24 101.24 103.76 104.57 102.68 95.63 94.04 93.74 95.31 98.09 98.44 98.99 98.63 99.43 99.74 100.52 101.70
Operating Income -0 3 4 2 -1 -4 -5 -3 6 8 10 9 4 4 2 3 1 1 -1 -4
Change (%) -786.82 22.47 -42.18 -148.83 217.08 34.47 -36.59 -276.03 48.70 24.15 -13.88 -54.32 -9.34 -33.44 36.65 -57.78 -54.93 -297.01 224.38
% of Revenue -0.68 4.30 5.12 2.76 -1.24 -3.76 -4.57 -2.68 4.37 5.96 6.26 4.69 1.91 1.56 1.01 1.37 0.57 0.26 -0.52 -1.70
Interest Expense -2 -2 -2 -2 -2 -2 -2 -2 -2 -2 -4 -5 -6 -8 -7 -7 -8 -6 -8 -7
Change (%) 1.57 2.89 0.52 3.00 0.75 -1.49 2.12 2.92 10.15 67.12 21.69 26.91 34.13 -14.56 8.68 12.62 -24.16 29.20 -9.68
% of Revenue -2.54 -2.37 -2.38 -2.23 -2.11 -2.03 -1.81 -1.71 -1.63 -1.65 -2.33 -2.47 -2.79 -3.36 -2.81 -3.01 -3.37 -2.57 -3.37 -3.08
Net Income -5 1 -14 -5 -6 -10 8 2 5 7 2 0 -3 -5 -5 -5 -7 -6 -9 -10
Change (%) -131.32 -1,080.38 -63.09 19.14 56.64 -180.00 -79.68 207.82 50.75 -79.31 -79.46 -998.06 65.12 -0.24 12.23 31.40 -5.97 36.20 16.51
% of Revenue -6.29 1.82 -17.35 -5.96 -6.54 -9.79 7.09 1.33 3.79 5.25 0.92 0.16 -1.32 -1.95 -1.90 -2.11 -2.75 -2.60 -3.60 -4.23

Source: Capital IQ

Other Listings
US:QIPT US$ 2.59
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista